{"id":{"repo_id":"sdstate","oai_identifier":"oai:openprairie.sdstate.edu:etd-2196"},"canonical_url":"https://search.dev.ndltd.org/etd/sdstate/oai:openprairie.sdstate.edu:etd-2196","repository":{"repo_id":"sdstate","name":"South Dakota State University","base_url":"https://openprairie.sdstate.edu/do/oai/"},"display":{"title":"Cardiovascular Risk, Remote Ischemic Postconditioning, and Endothelial Ischemia-Reperfusion Injury","abstract":"<p>Remote ischemic postconditioning (rIpost) is a potent vasculoprotective stimulus that is thought to reduce reperfusion injury associated with heart disease. However, certain animal models of cardiometabolic risk factors such as dyslipidemia, diabetes, and hypertension suggest the beneficial effects of rIpost to lessen reperfusion injury may be diminished. These findings have not been studied in clinically relevant humans. The aim of this study was to determine whether the protective effects of rIpost are reduced in the context of raised cardiometabolic risk in humans. Seven participants with raised cardiometabolic risk burden (age:57±7 years; BMI: 31±4kgm<sup>2</sup>participated in this 2X2 randomized cross-over design study. Raised cardiometabolic risk was established by the presence of 2 or more major risk factors and a 10-year Framingham risk score ≥10%. Microvascular endothelial function was measured using peripheral arterial tonometry (EndoPAT 2000, Itamar Medical Inc.) before and after 20 minutes of left arm, brachial artery ischemia, with and without the induction of rIpost (three, 5-minute bouts of right arm ischemia and reperfusion at 220 mmHg). Remote Ipost procedures were initiated immediately at the onset of reperfusion injury. Microvascular endothelial function was also assessed during a sham trial consisting of mock occlusions at the brachial artery (three, 5-minute inflations at 20 mmHg).</p>","abstract_html":"&lt;p&gt;Remote ischemic postconditioning (rIpost) is a potent vasculoprotective stimulus that is thought to reduce reperfusion injury associated with heart disease. However, certain animal models of cardiometabolic risk factors such as dyslipidemia, diabetes, and hypertension suggest the beneficial effects of rIpost to lessen reperfusion injury may be diminished. These findings have not been studied in clinically relevant humans. The aim of this study was to determine whether the protective effects of rIpost are reduced in the context of raised cardiometabolic risk in humans. Seven participants with raised cardiometabolic risk burden (age:57±7 years; BMI: 31±4kgm&lt;sup&gt;2&lt;/sup&gt;participated in this 2X2 randomized cross-over design study. Raised cardiometabolic risk was established by the presence of 2 or more major risk factors and a 10-year Framingham risk score ≥10%. Microvascular endothelial function was measured using peripheral arterial tonometry (EndoPAT 2000, Itamar Medical Inc.) before and after 20 minutes of left arm, brachial artery ischemia, with and without the induction of rIpost (three, 5-minute bouts of right arm ischemia and reperfusion at 220 mmHg). Remote Ipost procedures were initiated immediately at the onset of reperfusion injury. Microvascular endothelial function was also assessed during a sham trial consisting of mock occlusions at the brachial artery (three, 5-minute inflations at 20 mmHg).&lt;/p&gt;","abstract_has_math":false,"creators":["Hemenway, Brian A."],"institution":null,"degree_name":"Master of Science (MS)","degree_level":"Thesis - Open Access","degree_discipline":"Health and Nutritional Sciences","degree_department":null,"school":null,"contributors":["Gary P. Van Guilder"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2017,"date_issued":"2017-01-01T08:00:00Z","date_published":"2017-01-01T08:00:00Z","updated_at":"2026-07-24T04:28:43Z","subjects":["cardioprotection","cardiovascular disease","endothelial function","ischemia-reperfusion injury","ischemic conditioning","revascularization surgery","Exercise Physiology","Exercise Science","Rehabilitation and Therapy"],"languages":["en"],"rights":[],"rights_urls":["http://rightsstatements.org/vocab/InC/1.0/"],"identifier_entries":[]},"links":{"outbound_url":"https://openprairie.sdstate.edu/etd/1197","outbound_label":"Repository record","outbound_source":"dc:identifier"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Gary P. Van Guilder"]},{"key":"dc:creator","label":"Author","values":["Hemenway, Brian A."]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.available","label":"Dc Date Available","values":["2017-05-10T07:00:00Z"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Health and Nutritional Sciences"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Thesis - Open Access"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Master of Science (MS)"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["cardioprotection","cardiovascular disease","endothelial function","ischemia-reperfusion injury","ischemic conditioning","revascularization surgery","Exercise Physiology","Exercise Science","Rehabilitation and Therapy"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["en"]},{"key":"dc:rights","label":"Dc Rights","values":["http://rightsstatements.org/vocab/InC/1.0/"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://openprairie.sdstate.edu/etd/1197"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["<p>Remote ischemic postconditioning (rIpost) is a potent vasculoprotective stimulus that is thought to reduce reperfusion injury associated with heart disease. However, certain animal models of cardiometabolic risk factors such as dyslipidemia, diabetes, and hypertension suggest the beneficial effects of rIpost to lessen reperfusion injury may be diminished. These findings have not been studied in clinically relevant humans. The aim of this study was to determine whether the protective effects of rIpost are reduced in the context of raised cardiometabolic risk in humans. Seven participants with raised cardiometabolic risk burden (age:57±7 years; BMI: 31±4kgm<sup>2</sup>participated in this 2X2 randomized cross-over design study. Raised cardiometabolic risk was established by the presence of 2 or more major risk factors and a 10-year Framingham risk score ≥10%. Microvascular endothelial function was measured using peripheral arterial tonometry (EndoPAT 2000, Itamar Medical Inc.) before and after 20 minutes of left arm, brachial artery ischemia, with and without the induction of rIpost (three, 5-minute bouts of right arm ischemia and reperfusion at 220 mmHg). Remote Ipost procedures were initiated immediately at the onset of reperfusion injury. Microvascular endothelial function was also assessed during a sham trial consisting of mock occlusions at the brachial artery (three, 5-minute inflations at 20 mmHg).</p>"]},{"key":"dc:title","label":"Title","values":["Cardiovascular Risk, Remote Ischemic Postconditioning, and Endothelial Ischemia-Reperfusion Injury"]}]}],"canonical_facts":{"dc:contributor":["Gary P. Van Guilder"],"dc:creator":["Hemenway, Brian A."],"dc:date.available":["2017-05-10T07:00:00Z"],"dc:description.abstract":["<p>Remote ischemic postconditioning (rIpost) is a potent vasculoprotective stimulus that is thought to reduce reperfusion injury associated with heart disease. However, certain animal models of cardiometabolic risk factors such as dyslipidemia, diabetes, and hypertension suggest the beneficial effects of rIpost to lessen reperfusion injury may be diminished. These findings have not been studied in clinically relevant humans. The aim of this study was to determine whether the protective effects of rIpost are reduced in the context of raised cardiometabolic risk in humans. Seven participants with raised cardiometabolic risk burden (age:57±7 years; BMI: 31±4kgm<sup>2</sup>participated in this 2X2 randomized cross-over design study. Raised cardiometabolic risk was established by the presence of 2 or more major risk factors and a 10-year Framingham risk score ≥10%. Microvascular endothelial function was measured using peripheral arterial tonometry (EndoPAT 2000, Itamar Medical Inc.) before and after 20 minutes of left arm, brachial artery ischemia, with and without the induction of rIpost (three, 5-minute bouts of right arm ischemia and reperfusion at 220 mmHg). Remote Ipost procedures were initiated immediately at the onset of reperfusion injury. Microvascular endothelial function was also assessed during a sham trial consisting of mock occlusions at the brachial artery (three, 5-minute inflations at 20 mmHg).</p>"],"dc:identifier":["https://openprairie.sdstate.edu/etd/1197"],"dc:language":["en"],"dc:rights":["http://rightsstatements.org/vocab/InC/1.0/"],"dc:subject":["cardioprotection","cardiovascular disease","endothelial function","ischemia-reperfusion injury","ischemic conditioning","revascularization surgery","Exercise Physiology","Exercise Science","Rehabilitation and Therapy"],"dc:title":["Cardiovascular Risk, Remote Ischemic Postconditioning, and Endothelial Ischemia-Reperfusion Injury"],"thesis:degree_discipline":["Health and Nutritional Sciences"],"thesis:degree_level":["Thesis - Open Access"],"thesis:degree_name":["Master of Science (MS)"]},"updated_at":"2026-07-24T04:28:43Z"}